2017
DOI: 10.1016/j.oooo.2017.03.051
|View full text |Cite
|
Sign up to set email alerts
|

An update on myofibromas and myofibromatosis affecting the oral regions with report of 24 new cases

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

5
23
2
7

Year Published

2017
2017
2024
2024

Publication Types

Select...
4
2

Relationship

1
5

Authors

Journals

citations
Cited by 31 publications
(37 citation statements)
references
References 98 publications
5
23
2
7
Order By: Relevance
“…Case specifics for 20 of our 24 MFs have been reported previously in the literature (Smith et al [14], cases 1-11, 13, 15-17, 19-21, 23, 24 are cases 1-20 in the present paper). Distinct nuclear positivity for STAT6 was lacking in all 24 MFs.…”
Section: Resultssupporting
confidence: 77%
See 2 more Smart Citations
“…Case specifics for 20 of our 24 MFs have been reported previously in the literature (Smith et al [14], cases 1-11, 13, 15-17, 19-21, 23, 24 are cases 1-20 in the present paper). Distinct nuclear positivity for STAT6 was lacking in all 24 MFs.…”
Section: Resultssupporting
confidence: 77%
“…Since the discovery of NAB2/STAT6's role in SFT tumorigenesis [5][6][7] and the subsequent advent of STAT6 immunohistochemical marker, SFTs are more easily Table 2 Previously performed IHC results for 24 cases of MF; Cases 1-20 have been published prior in the literature [14] MF Previous IHC 1 αSMA+, desmin-, S100-, focal calponin+ 2 αSMA+, desmin-, vimentin+, CD34-, S100-3 αSMA+, desmin-, vimentin +, S100-4 αSMA+, MSA+, desmin-, S100-, CD34-5 αSMA+, MSA+, desmin-, vimentin +, S100-6 αSMA+, desmin-,S100-7 αSMA+, desmin-,S100-8 αSMA+, desmin-,S100-, CD34-9 αSMA+, MSA+, desmin-, H-caldesmon-, S100-10 αSMA+, MSA+, desmin-, vimentin+, AE1/3-, S100-11 αSMA+, desmin-,CD68-, AE1/3-, Cam 5.2-, S100-12 αSMA+, MSA+, desmin-, vimentin +, S100-13 αSMA+, desmin-,S100-, CD34-14 αSMA+, desmin-,S100-, CD68-15 αSMA+, MSA-, desmin-, S100-16 αSMA+, desmin-, CD34-, S100-, CD68-17 αSMA+, desmin-, CD34-, CD68-18 αSMA+, MSA+, desmin-, vimentin +, S100-, Factor 8-, CD68-19 αSMA+, desmin-,S100-, CD34-20 αSMA+, MSA+, desmin-,vimentin+ 21 αSMA+, MSA+, desmin-, CD68-, CD34-, S100-22 αSMA+, desmin-, S100-, CD68-23 αSMA+, desmin-, S100-24 αSMA+, S100- differentiated from other soft tissue tumors. While multiple researchers have reported the sensitivity and specificity of STAT6 expression in SFTs and its histopathologic mimickers [8][9][10][11][12][13], we were only able to find information about its expressivity in MFs for five cases in the literature: one case in a large series by Demicco et al (which reported negative STAT6 expressivity) [8] and four cases in a study by Yoshida et al [13].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Myofibromas are benign tumors composed of myofibroblastic cells . One‐third of the lesions occur in the head and neck region, gnathic bones being occasionally affected . Solitary intra‐osseous myofibroma usually appears as a well‐defined unilocular or multilocular radiolucency in the posterior mandible of children and adolescents .…”
Section: Introductionmentioning
confidence: 99%
“…6 One-third of the lesions occur in the head and neck region, gnathic bones being occasionally affected. 7 Solitary intra-osseous myofibroma usually appears as a well-defined unilocular or multilocular radiolucency in the posterior mandible of children and adolescents. 6 It usually shows a histopathologic biphasic pattern composed of elongated spindle to polygonal cells in a fibromyxoid stroma interspersed with bands of collagen, forming a zoning effect, which may not be evident in some cases.…”
mentioning
confidence: 99%